Theralase Technologies Inc. (TSXV: TLT)

Theralase Technologies Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	62	40	69	77	39	69
Market Cap Growth	-18.67%	-42.29%	-9.56%	97.37%	-44.12%	63.47%
Enterprise Value	62	40	67	72	30	55
Last Close Price	0.25	0.17	0.32	0.38	0.19	0.34
PS Ratio	58.93	37.35	60.85	98.13	41.77	72.04
PB Ratio	28.70	20.98	22.40	15.11	4.24	5.01
P/TBV Ratio	19.51	20.98	22.40	15.11	4.24	5.02
EV/Sales Ratio	62.77	37.52	59.13	91.82	32.43	56.67
Debt / Equity Ratio	0.15	0.20	0.15	0.01	0.01	0.01
Asset Turnover	0.32	0.29	0.23	0.10	0.07	0.10
Inventory Turnover	0.83	0.89	0.97	0.92	1.17	0.79
Quick Ratio	1.10	0.60	2.85	4.56	10.18	8.80
Current Ratio	1.91	1.39	3.67	5.71	10.85	9.33
Return on Equity (ROE)	-229.60%	-182.91%	-128.27%	-61.98%	-48.64%	-99.82%
Return on Assets (ROA)	-87.66%	-77.21%	-64.71%	-35.56%	-28.06%	-46.90%
Return on Capital (ROIC)	-121.27%	-98.03%	-75.41%	-39.53%	-30.76%	-59.52%
Earnings Yield	-7.45%	-11.43%	-7.56%	-5.76%	-14.42%	-10.67%
FCF Yield	-6.68%	-10.28%	-7.47%	-5.39%	-11.88%	-10.22%
Buyback Yield / Dilution	-7.23%	-5.79%	-1.79%	-	-41.19%	-10.88%
Total Shareholder Return	-7.23%	-5.79%	-1.79%	-	-41.19%	-10.88%

Source: S&P Capital IQ. Standard template. Financial Sources.